Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBASIC SCIENCE INVESTIGATIONS

Cell Culture and Xenograft-Bearing Animal Studies of Radiolabeled Antisense DNA–Carrier Nanoparticles with Streptavidin as a Linker

Kayoko Nakamura, Yi Wang, Xinrong Liu, Atsushi Kubo and Donald J. Hnatowich
Journal of Nuclear Medicine November 2007, 48 (11) 1845-1852; DOI: https://doi.org/10.2967/jnumed.106.039339
Kayoko Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinrong Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Kubo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald J. Hnatowich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    Size-exclusion HPLC radiochromatograms of free 99mTc-labeled PO-cDNA before (trace A) and after (trace B) addition to naked PS DNA (trace B) and after addition to PS DNA as the DNA–streptavidin–Tat nanoparticle (trace C). The retention time of the nanoparticle is confirmed by UV absorbance at 280 nm (trace D). The slight shoulder in the radioactivity profile of the DNA–streptavidin–Tat nanoparticle at higher MW is evidence that the contribution of higher-order products was no more than about 10%.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    Histogram showing average percent accumulation at 3 h (□), 7 h (▪), and 23 h (Embedded Image) of 99mTc-labeled PO DNA incubated as Tat, polyarginine (PolyA), and cholesterol (CHO) nanoparticles or carrier-free nanoparticle in KB-31, KB-G2, and TCO-1 cells (n = 3; error bars indicate 1 SD).

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    Histogram showing average percent accumulation at 3 h (□), 7 h (▪), and 23 h (Embedded Image) of 99mTc-labeled PS DNA incubated as Tat, polyarginine (PolyA), and cholesterol (CHO) nanoparticles or carrier-free nanoparticle in KB-31, KB-G2, and TCO-1 cells (n = 3; error bars indicate 1 SD). Note that scale differs from that in Figure 2.

Tables

  • Figures
    • View popup
    TABLE 1

    Biodistribution in KB-G2 Xenograft–Bearing Mice of 99mTc-Labeled PS DNA–Streptavidin–Cholesterol, PS DNA–Streptavidin–Tat, and PO DNA–Streptavidin–Tat Nanoparticles with Sacrifice at 6 Hours and 18 Hours (n = 3)

    PS DNA–streptavidin– cholesterol nanoparticlePS DNA–streptavidin– Tat nanoparticlePO DNA–streptavidin– Tat nanoparticle
    Time (h)Tissue%ID/gSDT/BSD%ID/gSDT/BSD%ID/gSDT/BSD
    6Blood0.0990.0130.1470.0150.0460.004
    Heart0.1370.0231.380.1800.2060.0101.420.1560.0530.0061.140.032
    Lung0.3000.0523.120.0220.5320.1073.640.6970.1240.0332.720.967
    Liver9.131.5094.226.614.71.4410116.72.790.44859.94.21
    Spleen3.390.43635.09.815.350.35136.84.771.190.14025.50.686
    Stomach1.011.239.6811.76.277.5040.045.70.1220.0242.620.288
    Large intestine0.8680.4868.433.970.7730.3655.152.060.1690.0243.690.844
    Kidney0.8660.1268.851.771.320.0589.081.000.4480.0649.630.503
    Muscle0.0260.0030.2640.0680.0480.0030.3320.0440.0130.0010.2730.036
    Bone0.3990.0164.090.7610.6620.0694.510.2140.1010.0162.200.542
    Tumor0.1790.0371.810.2920.2320.0261.600.2610.0680.0131.460.225
    18Blood0.0500.0110.0440.0100.0140.001
    Heart0.0920.0071.910.2990.1040.0252.340.3090.0260.0021.900.072
    Lung0.2450.0604.980.8920.2270.0235.311.410.1110.0097.981.09
    Liver8.041.7516528.69.933.3622350.62.600.45118515.4
    Spleen2.730.44147.516.52.640.37748.97.721.060.01588.714.6
    Stomach0.1920.0783.950.7110.1650.13010.010.90.0630.0105.771.83
    Large intestine0.3830.05813.011.10.5500.23627.424.60.0740.02014.114.6
    Kidney0.6790.13613.80.6750.6940.11315.92.280.2260.03016.10.731
    Muscle0.0220.0080.4220.0790.0210.0060.4640.0640.0080.0010.5500.066
    Bone0.4050.1238.131.480.3890.0658.870.6690.1130.0198.100.620
    Tumor0.1230.0302.480.2900.1270.0182.940.5090.0390.0062.750.315
    • T/B = tissue-to-blood ratio.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (11)
Journal of Nuclear Medicine
Vol. 48, Issue 11
November 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cell Culture and Xenograft-Bearing Animal Studies of Radiolabeled Antisense DNA–Carrier Nanoparticles with Streptavidin as a Linker
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Cell Culture and Xenograft-Bearing Animal Studies of Radiolabeled Antisense DNA–Carrier Nanoparticles with Streptavidin as a Linker
Kayoko Nakamura, Yi Wang, Xinrong Liu, Atsushi Kubo, Donald J. Hnatowich
Journal of Nuclear Medicine Nov 2007, 48 (11) 1845-1852; DOI: 10.2967/jnumed.106.039339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cell Culture and Xenograft-Bearing Animal Studies of Radiolabeled Antisense DNA–Carrier Nanoparticles with Streptavidin as a Linker
Kayoko Nakamura, Yi Wang, Xinrong Liu, Atsushi Kubo, Donald J. Hnatowich
Journal of Nuclear Medicine Nov 2007, 48 (11) 1845-1852; DOI: 10.2967/jnumed.106.039339
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Auger Radiation-Induced, Antisense-Mediated Cytotoxicity of Tumor Cells Using a 3-Component Streptavidin-Delivery Nanoparticle with 111In
  • A Generalizable Strategy for Imaging pre-mRNA Levels in Living Subjects Using Spliceosome-Mediated RNA Trans-Splicing
  • Google Scholar

More in this TOC Section

  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire